Intranasal Oxytocin for Infants With Prader-Willi Syndrome

Summary

The purpose of this study is to compare the change in suck and swallow competency from baseline to morning of day 6 with intranasal oxytocin spray vs placebo in infants/children with Prader-Willi Syndrome who are in nutritional phase 1a. Videofluoroscopic swallow studies will be performed on treatment day 1 and on the day following treatment morning of day 6.

Timeline

Start

2017-08-01

Primary completion

2018-01-04

Completion

2018-01-04

Drugs

Indications